Pharmacist's contribution in a heart function clinic: Patient perception and medication appropriateness

Canadian Journal of Cardiology

Volumn 19, Issue 4, 2003, Pages 391-396

  Bucci, Claudia ^a   Jackevicius, Cynthia ^a   McFarlene, Karen ^a   Liu, Peter ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Ambulatory clinic; Congestive heart failure; Pharmacist

Indexed keywords

CARDIAC AGENT;

ADULT; AGED; AMBULATORY CARE; ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEEDBACK SYSTEM; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH SURVEY; HEART FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL CARE; MEDICAL STAFF; OUTCOMES RESEARCH; OUTPATIENT DEPARTMENT; PATIENT ATTITUDE; PATIENT EDUCATION; PATIENT GUIDANCE; PERCEPTION; PHARMACIST; PRACTICE GUIDELINE; PRESCRIPTION; PROFESSIONAL PRACTICE; RANDOMIZED CONTROLLED TRIAL; SALARY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

AGED; CARDIOTONIC AGENTS; CONTINUITY OF PATIENT CARE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEALTH SERVICES RESEARCH; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; ONTARIO; PATIENT CARE TEAM; PATIENT SATISFACTION; PHARMACEUTICAL SERVICES; PHARMACIES; PHARMACISTS; PILOT PROJECTS; PROFESSIONAL ROLE;

EID: 0037615125     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Deady JE Lepinski PW, Abramowitz PW. Measuring the ability of clinical pharmacists to effect drug therapy changes in a family practice clinic using prognostic indicators. Hosp Pharm 1991;26:93-7.
2. Sczupak CA, Conrad WF. Relationship between patient-oriented pharmaceutical services and therapeutic outcomes of ambulatory patients with diabetes mellitus. Am J Hosp Pharm 1977;34:1238-42.
3. Hawkins DW, Fiedler FP, Douglas HL, Eschbach RC. Evaluation of a clinical pharmacist in caring for hypertensive and diabetic patients. Am J Hosp Pharm 1979;36:1321-5.
4. Morse GD, Douglas JB, Upton JH, Rodgers S, Gal P. Effect of pharmacist intervention on control of resistnat hypertension. Am J Hosp Pharm 1986;43:905-9.
5. Gray DR, Garabedian-Ruffalo SM, Chretien SD. Cost-justification of a clinical pharmacist-managed anticoagulation clinic. Drug Intell Clin Pharm 1985;19:575-80.
6. Nelson AA, Beno CE, Davis RE. Task and cost analysis of integrated clinical pharmacy services in private family practice centers. J Fam Pract 1983;16:111-6.
7. Chrischilles EA, Helling DK, Rowland CR. Clinical pharmacy services in family practice: Cost-benefit analysis. I: Physician time and quality of care. Drug Intell Clin Pharm 1984;18:333-41.
8. Goodyear L, Miskelly F, Milligan P. Does encouraging good compliance improve patient's clinical condition in heart failure? Br J Clin Pharm 1995;49:173-6.
9. Smith LE, Fabbri SA, Pai R, Ferry D, Heywood T. Symptomatic improvement and reduced hospitalization for patients attending a cardiomyopathy clinic. Clin Cardiol 1997;20:949-54.
10. Paul S. Implementing an outpatient congestion heart failure clinic: The nurse practitioner role. Heart Lung 1997;26:486-91.
11. Stewart S, Pearson S, Luke CG, Horowitz JD. Effects of home-based intervention on unplanned readmissions and out of hospital deaths. J Am Geriatr Soc 1998;46:174-80.
12. Stewart S, Pearson S, Horowitz. Effect of a home-based intervention among patients with congestive heart failure discharge from acute hospital care. Arch Intern Med 1998;158:1067-72.
13. Rainville EC. Impact of pharmacist interventions on hospital readmissions for heart failure. Am J Health Syst Pharm 1999;56:1339-42.
14. Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 1995;333:1190-5.
15. Gattis WA, Hasselblad V, Whellam DJ, O'Connor CM. Reduction in heart failure events by clinical pharmacist intervention: Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) study. Arch Intern Med 1998;159:1939-45.
16. Johnstone DE, Abdulla A, Arnold JMO, et al. Canadian Cardiovascular Society Consensus Conference: Diagnosis and management of heart failure. Can J Cardiol 1994;10:613-31.
17. Brophy JM. Epidemiology of congestive heart failure: Canadian data from 1980 to 1989. Can J Cardiol 1992;8:495-8.
18. McMurray J, Mcdonagh T, Morrison C, Dargie H. Trends in hospitalization for heart failure in Scotland 1980-1990. Eur Heart J 1993;14:1158-62.
19. Clelland JG, Swedberg K, Poole-Wilson PA. Successes and failures of current treatment of heart failure. Lancet 1998;352:19-28.
20. Rich MW, Brooks K, Luther P. Temporal trends in pharmacotherapy for congestive heart failure at an academic medical center: 1990-1995. Am Heart J 1998; 135:367-72.
21. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47:533-43.
22. Austin Z. Towards seamless care: A commentary. Hosp Pharm Pract 1995;3:17-21.
23. Harrison MB, Toman C, Logan J. Hospital to home: Evidence-based education for CHF. Can Nurse 1998; February: 36-42.
24. Ghali J. Heart failure and noncompliance in the elderly. Arch Intern Med 1994;154:2109-10. [Lett]
25. Kravitz RL, Hays RD, Sherbourne CD, et al. Recall of recommendations and adherence among patients with chronic medical conditions. Arch Intern Med 1993;153:1869-78.
26. Hanlon JT, Weinberger M, Samsa GP, et al. A randomized controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med 1996;100:428-37.
27. Samsa GP, Hanlon JT, Schmader KE, et al. A summated score for the medication appropriateness index: Development and assessment of clinimetric properties including content validity. J Clin Epidemiol 1994;47:891-6.
28. Fitzgerald LS, Hanlon JT, Shelton PS, Landsman PB, Schmader KE, Pulliam CC. Reliability of a modified medication appropriateness index in ambulatory older persons. Ann Pharmacother 1997;31:543-8.
29. Gupchup GV, Wolfgang AP, Thomas J. Development of a scale to measure directive guidance by pharmacists. Ann Pharmacother 1996;30:1369-75.
30. The 2001 Canadian Cardiovascular Society Consensus Guideline Update for the Management and Prevention of Heart Failure. Can J Cardiol 2001;17(Suppl E):5E-25E.
31. Rosner R. Fundamentals of Biostatistics, 4th edn. Toronto: Duxbury Press, 1995.
32. Schmader K, Hanton JT, Weinberger M, et al. Appropriateness of medication prescribing in ambulatory elderly patients. J Am Geriatr Soc 1994;42:1241-7.
33. Philbin EF. Current community practices in heart failure: Understanding the under utilization of angiotensin-converting enzyme inhibitors. J Am Coll Cardiol 1997. (Abst 325A)
34. Sueta CA, Chowdhury M, Boccuzzi SJ, et al. Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary heart disease. Am J Cardiol 1999;83:1303-7.
35. Rich MW, Brooks K, Luther P. Temporal trends in pharmacotherapy for congestive heart failure at an academic medical center: 1990-1995. Am Heart J 1998;135:367-72.
36. Murray MR. Medication appropriateness index: Putting a number on an old problem in older patients. Ann Pharm 1997;31:643-4.
37. Kong SX, Wertheimer AI. Social support: Concepts, theories and implications for pharmacy research. J Pharm Mark Manage 1994;9:63-90.
38. Lerman CE, Brody DS, Caputo GC et al. Patients' perceived involvement in care scale: Relationship to attitudes about illness and medical care. J Gen Intern Med 1990;5:29-33.
39. Brody DS, Miller SM, Lerman CE, et al. The relationship between patients' satisfaction with their physicians and perceptions about interventions they desired and received. Med Care 1989;27:1027-35.
40. Nau DP, Ried LD, Lipowski EE, et al. Patients' perception of the benefits of pharmaceutical care. J Am Pharm Assoc 2000;40:36-40.